Published online May 20, 2022. doi: 10.5662/wjm.v12.i3.92
Peer-review started: October 19, 2021
First decision: January 18, 2022
Revised: February 5, 2022
Accepted: March 26, 2022
Article in press: March 26, 2022
Published online: May 20, 2022
Processing time: 211 Days and 10.5 Hours
Core Tip: Systematic reviews with or without meta-analyses provide the highest quality of evidence, thus lying on the top of evidence-based medicine hierarchy. However, pair-wise meta-analyses present the inherent limitation of exclusively comparing direct evidence. By contrast, Network Meta-Analyses (NMAs) also consider indirect evidence, thereby offering additional useful information. Conducting an NMA, however, has certain requirements such as assuming that transitivity across the included studies exists. What is more, maintaining sufficient statistical power in the analyses is crucial. In addition, performing head-to-head statistical comparisons before setting up networks of interventions is a prerequisite for a methodologically sound NMA, and selecting not only positive but also negative outcomes is required. Lastly, implementing quality appraisal systems to grade the level of evidence is highly recommended. Should all the above criteria be fulfilled, then accurate clinical conclusions can be drawn from an NMA.
